Consensus Recommendations from the 2024 International Follicular Lymphoma Scientific Workshop

By afschroeder • December 4, 2025

Merryman RW, Rutherford SC, Ansell SM, Armand P, Leonard JP, Nastoupil L, Smith SM, Timmerman JM, Zelenetz AD, Gutierrez M, Béguelin W, Casulo C, Cerhan JR, Green MR, Kahl BS, Kridel R, Link BK, Maurer MJ, Nadel B, Radtke A, Luttwak E, Salles GA, Sehn LH, Pasqualucci L, LaCasce AS. Consensus Recommendations from the 2024 International Follicular Lymphoma Scientific Workshop. Blood Adv. 2025 Dec 3:bloodadvances.2025018079. doi: 10.1182/bloodadvances.2025018079. Epub ahead of print. PMID: 41337699.

Tags: Hematology/Oncology, Publications

Regorafenib use in patients with unresectable hepatocellular carcinoma: analyses of subgroups of special interest in the observational REFINE study

Kim YJ, Merle P, Finn RS, Klümpen HJ, Lim HY, Ikeda M, Granito A, Masi G, Gerolami R, Pinter M, Babajanyan S, Twumasi-Ankrah P, Ghadessi[...]

Differential responses to sequential menin inhibitor therapy for acute leukemia underscore the complexities of acquired resistance

Markosian C, Buckley CW, Chai-Ho W, Schiller GJ. Differential responses to sequential menin inhibitor therapy for acute leukemia underscore the complexities of acquired resistance. Leuk[...]

Sequential transcriptional waves and NF-κB-driven chromatin remodeling direct drug-induced dedifferentiation in cancer

Su Y, Liu C, Lu X, Chuang HY, Li G, Shao S, Kong Y, Lee JW, Ng RH, Wong S, Robert L, Warden C, Liu[...]